Heidelberg Pharma AG Total Liabilities

Latest as of May 2025: €43.94 Million EUR ≈ $51.37 Million USD

Heidelberg Pharma AG total liabilities. Based on the latest financial reports, Heidelberg Pharma AG (HPHA) has total liabilities worth €43.94 Million EUR (≈ $51.37 Million USD) as of May 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. See HPHA cash and liquid assets coverage to measure how many days the company can operate on defensive assets alone.

Total Liabilities of Heidelberg Pharma AG (2016–2024)

Total liabilities of Heidelberg Pharma AG from 2016 to 2024. This chart illustrates how Heidelberg Pharma AG's total liabilities have evolved over time, based on quarterly financial data.

Heidelberg Pharma AG Competitors by Total Liabilities

The table below lists competitors of Heidelberg Pharma AG ranked by their total liabilities.

Company	Country	Total Liabilities
Soquicom SN:SOQUICOM	Chile	CL$66.29 Million
Hennessy Capital Investment Corp. VII Unit NASDAQ:HVIIU	USA	$10.79 Million
Stellar Resources Ltd AU:SRZ	Australia	AU$621.89K
Tribeca Global Natural Resources Ltd AU:TGF	Australia	AU$68.42 Million
CSU Digital S.A. SA:CSUD3	Brazil	R$236.75 Million
Bank Negara Indonesia Tbk JK:BBNI	Indonesia	Rp1036.47 Trillion
OCK Group Bhd KLSE:0172	Malaysia	RM1.29 Billion
GnBS Engineering Co. Ltd. KQ:382800	Korea	₩30.41 Billion

Liability Composition Analysis (2016–2024)

This chart breaks down Heidelberg Pharma AG's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see HPHA total assets.

Liquidity & Leverage Metrics

Heidelberg Pharma AG Total Liabilities Ratios Explained

Heidelberg Pharma AG total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric	Value	Description
Current Ratio	7.74	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	2.37	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.70	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Heidelberg Pharma AG's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Heidelberg Pharma AG (2016–2024)

The table below shows the annual total liabilities of Heidelberg Pharma AG from 2016 to 2024.

Year	Total Liabilities	Change
2024-11-30	€29.85 Million ≈ $34.90 Million	+42.08%
2023-11-30	€21.01 Million ≈ $24.57 Million	-38.08%
2022-11-30	€33.94 Million ≈ $39.68 Million	+125.75%
2021-11-30	€15.03 Million ≈ $17.58 Million	+123.39%
2020-11-30	€6.73 Million ≈ $7.87 Million	+0.49%
2019-11-30	€6.70 Million ≈ $7.83 Million	+26.22%
2018-11-30	€5.31 Million ≈ $6.20 Million	+18.81%
2017-11-30	€4.47 Million ≈ $5.22 Million	-18.58%
2016-11-30	€5.49 Million ≈ $6.41 Million	--

About Heidelberg Pharma AG

F:HPHA Germany Biotechnology

Market Cap

$111.58 Million

€95.44 Million EUR

Market Cap Rank

#18596 Global

#1721 in Germany

Share Price

€2.04

Change (1 day)

+2.00%

52-Week Range

€2.00 - €3.18

All Time High

€8.94